CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 306 enrolled
Drug / intervention
etanerceptdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00913458
NCT00913458Phase 4Completed
CompareCT.gov

A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate

Pfizer·interventional·Posted Jun 4, 2009·Updated Jul 17, 2014

In Brief

A Phase 4 clinical trial evaluating etanercept for Active Rheumatoid Arthritis and 2 related conditions. Completed, enrolled 306 participants across 59 sites in 13 countries.

Detailed Summary

Study to evaluate whether there is sustained remission and productivity in subjects with early rheumatoid arthritis started on etanercept plus methotrexate treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActive Rheumatoid Arthritis, Arthritis, Rheumatoid, Rheumatoid Arthritis
CountriesFrance, Germany, Ireland, Italy, Monaco, Netherlands, Poland, Qatar, Romania, Russia, Spain, Switzerland, United Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 4, 2009
Enrollment StartSep 1, 2009
Primary CompletionJun 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.1 years ago

Interventions

etanerceptdrug